Exclusive patent, know-how, process, technology and trade secret license to develop, make, have made, use, sell, have sold, import, export, improve and sublicense pharmaceutical products containing lasofoxifene tartrate alone or in combination with other active ingredients, for oral use in the treatment or prevention of human diseases, including metastatic breast cancer.